jump to navigation

MBBP Client MindChild Medical, Inc. Receives FDA Clearance of Fetal Heart Monitor 01/26/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Medical Devices.
Tags: , , , , , , , , ,
trackback

MindChild Medical, Inc., a client of MBBP, has received FDA clearance for its Pre-Marketing Notification (510(k)) for its MERIDIAN™ M110 non-invasive fetal heart monitor. The FDA clearance will enable MindChild to enter the U.S. market with MERIDIAN™.

MindChild’s MERIDIAN™ M110 Fetal Monitoring System is an intrapartum fetal monitor that externally measures and displays fetal heart rate, maternal heart rate, and uterine contractions.

MindChild was founded in 2008 and is a privately funded medical device company. To learn more about the MERIDIAN™ device and MindChild, read the full press release.

Congratulations to MindChild on this achievement!

Comments»

No comments yet — be the first.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: